Accelerate to discover

Back to filter

Related topics

Successful migration from radioactive irradiators to x-ray irradiators

Precision X-Ray

Dec 9, 2019

This paper summarizes about 9 years of effort by Mount Sinai to successfully migrate completely from radioactive...

New NovoCyte Advanteon - Performance you can trust with the flexibility you need

Acea Biosciences

Dec 6, 2019

The NovoCyte Advanteon flow cytometer builds upon the highly successful NovoCyte, and NovoCyte Quanteon, to provide an...

Bioflux webinar: Flow dynamics influence on biofilm formation by Proteus mirabilis

Fluxion Biosciences

Dec 2, 2019

Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...

Bruker MRI consistent quantification

Bruker Biospin

Nov 29, 2019

Regardless of the method, stability and reproducibility are a must for many laboratories. Identical protocols must...

Dec 10, 2019

Targeted sequencing of highly homologous genes using Cas9 digestion

Sage Science

Nov 25, 2019

Integrated DNA extraction, digestion, and size-selection using HLS-CATCH were introduced for addressing the problem of...

Multirad - Fully integrated x-ray irradiation system

Precision X-Ray

Nov 20, 2019

The new X-RAD 160 qube is suitable for either mounting on the lab bench or mobile on an optional wheeled cart, allowing...

AVATAR system: A unique capability for functional screening of tumor microenvironment

Xcell Biosciences

Nov 18, 2019

The AVATAR Cell Control System lets you generate your cells of interest and optimize to a growth rate, functional...

Dec 10, 2019

Zebrafish heart imaging

Bruker Biospin

Nov 14, 2019

Today watch this interesting video interview with Anabela Bensimon-Brito, Department of Developmental Genetics, Max...

Show all topics (10)

Preclinical PET imaging in studies of candidate therapeutics

Jun 22, 2017

Clinical and preclinical non-invasive PET imaging is employed in the development and validation of therapeutic agents for cancer and neurological disorders, and a range of other diseases. Reported studies have used numerous agents including FDG, FLT, FMISO and FAZA as early biomarkers of drug efficacy. Preclinical PET imaging has been proven in studies of therapeutic targeting and biodistribution, drug target interactions, pharmacodynamics and toxicology. These methods have helped facilitate the development of therapeutic agents that are now clinically available. Probably two of the most common uses of preclinical PET imaging in drug discovery are studies of compound targeting and biodistribution and therapeutic efficacy. In the article, you can find a brief introduction to preclinical PET imaging for such studies.

Read more

Scientific paper
Application

Related technologies: PET, SPECT, CT

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey